Evidence map›Paper›PMID 38739197›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2024

Sirt1 inhibits macrophage polarization and inflammation in gouty arthritis by inhibiting the MAPK/NF-κB/AP-1 pathway and activating the Nrf2/HO-1 pathway.

Xu Zhao, Menglan Li, Yiwei Lu, Mi Wang, Jiawei Xiao, Qingqing Xie, Xinyi He, Shiquan Shuai

Abstract read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Serum α-Klotho and SIRT1 - Relationship with graft function, inflammation and hospitalization rates in kidney transplant recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Observational
  16. Review
  17. CD63Frontiers in cellular and infection microbiology · 2026
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xu ZhaoDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China.
Menglan LiDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China.
Yiwei LuDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China.
Mi WangDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China.
Jiawei XiaoDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China.
Qingqing XieNanchong Key Laboratory of Inflammation and Immunization, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, Nanchong, 637000, Sichuan, China.
Xinyi HeDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China.
Shiquan ShuaiDepartment of Rheumatology and Immunology, Nanchong Central Hospital (Nanchong Clinical Research Center), The Second Clinical Medical College of North Sichuan Medical College, No. 97, Nanlu, Shunqing District, Nanchong, 637000, Sichuan, China. 200899539@qq.com.

Funding

2022 Nanchong City Science and Technology Plan Project 22JCYJPT0013
6 · The paper itself

Abstract

OBJECTIVE AND

designTo elucidate Sirt1's role in gouty arthritis inflammation and its potential mechanisms. MATERIAL: Constructed murine models of gouty arthritis and conducted THP-1 cell experiments. TREATMENT: 1 mg of MSU crystals injected into mice ankle joints for a 72-h intervention. After a 3-h pre-treatment with Sirt1-specific inhibitor (EX527) and agonist (SRT2104), inflammation was induced for 21 h using lipopolysaccharide (LPS) plus MSU crystals.

methodsWe assessed gouty arthritis severity through joint inflammation index, swelling, and hematoxylin and eosin (H&E) staining, and measured CD68 mononuclear macrophages and Sirt1 expression in synovial tissue via immunohistochemistry. ELISA, NO assay, RT-qPCR, Flow cytometry, and Western blot were utilized to examine macrophage inflammatory factors, polarization, reactive oxygen species(ROS), MAPK/NF-κB/AP-1 and Nrf2/HO-1 pathways proteins.

resultsSignificant joint swelling, synovial tissue edema, and inflammatory cell infiltration were observed. CD68 mononuclear macrophages and Sirt1 expression were elevated in synovium. Sirt1 activation decreased inflammatory factors, M1 polarization, and ROS generation. Sirt1 activation reduced p38/JNK phosphorylation, thereby inhibiting downstream NF-κB p65/AP-1 and enhancing Nrf2/HO-1, thus suppressing inflammation.

conclusionsSirt1 alleviates M1 macrophage polarization and inflammation in gouty arthritis by inhibiting the MAPK/NF-κB/AP-1 pathway and activating the Nrf2/HO-1 pathway. Thus, activating Sirt1 may provide a new therapeutic target for gouty arthritis.

Indexed as

Arthritis, GoutyHeme Oxygenase-1MacrophagesNF-E2-Related Factor 2NF-kappa BSirtuin 1Transcription Factor AP-1AnimalsCarbazolesHumansInflammationLipopolysaccharidesMaleMembrane ProteinsMiceMice, Inbred C57BL6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideCarbazolesHeme Oxygenase-1Hmox1 protein, mouseLipopolysaccharidesMembrane ProteinsNfe2l2 protein, mouseNF-E2-Related Factor 2NF-kappa BSirt1 protein, mouseSirtuin 1Transcription Factor AP-1Gouty arthritisMacrophage polarizationMAPK signaling pathwayOxidative stressSirt1

Identifiers

PMID38739197
PMCPMC11214610

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.